About Shyamal Intermediates
Shyamal Intermediates is a Chemicals & Materials company based in India. It manufactures and exports chemical intermediates for dyes and pharma industries from India. It operates on a B2B model in Chemicals & Materials and Healthcare sectors. The company has 6 employees. Its Indian entity Shyamal Intermediates Private Limited reported revenue of ₹5.67 Cr. Shyamal Intermediates offers products and services including Dyes Intermediates and Pharma Bulk Drug Intermediates. Its focus areas include Chemicals, Specialty Chemicals, Intermediates and Dyes Manufacturing. Its competitors include Viyash, Inventys and Blue Jet Healthcare; 2 of its 3 listed competitors have raised funding.
Company details
Shyamal Intermediates Ltd is a manufacturer and exporter based in India, focusing on producing high-quality chemical intermediates. Their products include pyrazolone derivatives, stilbene derivatives, and various bulk drug intermediates like phthalimide and its variants for the dyes and pharmaceuticals sectors. They operate through manufacturing processes for global export markets, serving industrial clients with specialized chemicals. The company emphasizes quality production and distribution.
- Headquarters India
- Employees 6
- SectorsChemicals & MaterialsHealthcare
- Email••••••••
- Website shyamalchemicals.com
- Legal Name Shyamal Intermediates Private Limited
- Date of Incorporation 19 Mar, 1990
- Jurisdiction Ahmedabad, Gujarat, India
- Annual Revenue₹5.67 Cr
FY 2025 · -54% YoY
- Net Loss-₹92 Lakh
FY 2025 · -16% margin
- EBITDA₹47.6 Lakh
FY 2025 · 8% margin
- Employee Count6
Associated legal entities of Shyamal Intermediates
Shyamal Intermediates operates through Shyamal Intermediates Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Shyamal Intermediates Private Limited CIN U24231GJ1990PTC013512 | Active | 19 Mar 1990 | Ahmedabad, Gujarat | ₹5.7 Cr | 6 | 4 | View details |
Products & Services of Shyamal Intermediates
Shyamal Intermediates offers a comprehensive portfolio of products and services, including Dyes Intermediates and Pharma Bulk Drug Intermediates.
Intermediates for dyestuffs production including pyrazolone derivatives.
Raw materials for drugs like phthalimide and variants.
Board of directors of Shyamal Intermediates Private Limited (Shyamal Intermediates)
Shyamal Intermediates Private Limited is the primary company behind Shyamal Intermediates. The board of Shyamal Intermediates Private Limited currently have 4 directors; the longest-serving is Subhashbhai Chimanlal Patel, appointed in 1990. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Subhashbhai Chimanlal Patel DIN 00031171 | Managing Director | 19 Mar 1990 | 36 yrs 7 mo | Shyamal Intermediates Private Limited |
| Rekhaben Subhashchandra Patel DIN 02149889 | Director | 31 Mar 1995 | 31 yrs 7 mo | Shyamal Intermediates Private Limited |
| Shyamal Subhashbhai Patel DIN 00040870 | Whole-time director | 01 Oct 2004 | 22 yrs 1 mo | Shyamal Intermediates Private Limited |
| Bhumikaben Patel DIN 08665504 | Director | 25 Dec 2019 | 6 yrs 10 mo | Shyamal Intermediates Private Limited |
Financials of Shyamal Intermediates
Figures of Shyamal Intermediates Private Limited, the primary company behind Shyamal Intermediates, for FY 2025. Revenue was ₹5.67 Cr (-54% year on year). Net loss was -₹92 Lakh (-16% margin). EBITDA was ₹47.6 Lakh (8% margin). Revenue has grown at a compounded annual rate of -26% over three years and -17% over five years.
- ₹5.67 CrRevenue · FY 2025 · -54% YoY
- -₹92 LakhNet loss · -16% margin
- ₹47.6 LakhEBITDA · 8% margin
- ₹99.8 LakhPaid-up capital
- 6Employees (provident fund records)
- -26%Revenue CAGR, 3 years
- -17%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Shyamal Intermediates Private Limited are on its company page.
Detailed financial statements for Shyamal Intermediates
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Shyamal Intermediates
Shyamal Intermediates has 3 listed competitors in our database, 2 of them funded. They include Viyash, Inventys and Blue Jet Healthcare.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| viyash.com | 2019 | Hyderabad, India | $120.02M | 277 | APIs and intermediates are manufactured by Viyash as a CDMO. | |
| inventys.in | 2005 | Mumbai, India | $64.34M | 219 | Actives, advanced intermediates, and specialty chemicals are custom manufactured. | |
| bluejethealthcare.com | 1969 | Mumbai, India | 476 | CDMO focused on manufacturing, supplier, and development of intermediates & APIs |
Detailed competitors of Shyamal Intermediates
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Shyamal Intermediates
Websites that share an audience with Shyamal Intermediates (shyamalchemicals.com).
Websites whose visitors overlap most with Shyamal Intermediates. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| crystalquinone.com | 100% | 1.1K | View details |
Top companies in Dyes, Pigments & Colorants
3 companies that operate in the same segment as Shyamal Intermediates (Dyes, Pigments & Colorants) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pigments and performance colorants are manufactured for diverse applications. | 1951 | Pune, Maharashtra, India | USD 82.81 M | 2,007 | ||
Reactive and intermediate dyes are manufactured by Yash Chemex. | 2006 | Ahmedabad, Gujarat, India | USD 15.35 M | 5 | ||
Dyes, dyes intermediates, and fertilizers are manufactured in India. | 1994 | Mumbai, Maharashtra, India | USD 103.7 M | 175 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Shyamal Intermediates
Shyamal Intermediates is headquartered in India.
Shyamal Intermediates has 6 employees.
The primary company behind Shyamal Intermediates, Shyamal Intermediates Private Limited, reported revenue of ₹5.67 Cr for FY 2025, down 54% year on year.
Shyamal Intermediates Ltd is a manufacturer and exporter based in India, focusing on producing high-quality chemical intermediates. Their products include pyrazolone derivatives, stilbene derivatives, and various bulk drug intermediates like phthalimide and its variants for the dyes and pharmaceuticals sectors. They operate through manufacturing processes for global export markets, serving industrial clients with specialized chemicals. The company emphasizes quality production and distribution.
Shyamal Intermediates's top competitors include Inventys, Viyash and Blue Jet Healthcare.
Shyamal Intermediates offers Dyes Intermediates and Pharma Bulk Drug Intermediates.
Shyamal Intermediates operates through Shyamal Intermediates Private Limited.
The legal entities of Shyamal Intermediates currently have 4 directors, including Bhumikaben Patel, Rekhaben Subhashchandra Patel, Subhashbhai Chimanlal Patel and others.